2024; 12:846.
. A Pseudovirus Nanoparticle Displaying the Vaccinia Virus L1 Protein Elicited High Neutralizing Antibody Titers and Provided Complete Protection to Mice against Mortality Caused by a Vaccinia Virus Challenge. Vaccines.A Viral Protein 4-Based Trivalent Nanoparticle Vaccine Elicited High and Broad Immune Responses and Protective Immunity against the Predominant Rotaviruses. ACS Nano. 2024; 18:6673-6689.
.Pseudovirus Nanoparticles Displaying Plasmodium Circumsporozoite Proteins Elicited High Titers of Sporozoite-Binding Antibody. Vaccines. 2023; 11.
.A bioengineered pseudovirus nanoparticle displaying SARS-CoV 2 RBD fully protects mice from mortality and weight loss caused by SARS-CoV 2 challenge. Biotechnology Journal. 2023; 18:e2300130.
.The αTSR Domain of Plasmodium Circumsporozoite Protein Bound Heparan Sulfates and Elicited High Titers of Sporozoite Binding Antibody After Displayed by Nanoparticles. International Journal of Nanomedicine. 2023; 18:3087-3107.
. .Mucosal and systemic neutralizing antibodies to norovirus induced in infant mice orally inoculated with recombinant rotaviruses. Proceedings of the National Academy of Sciences of USA. 2023; 120:e2214421120.
.A New Gnotobiotic Pig Model of P[6] Human Rotavirus Infection and Disease for Preclinical Evaluation of Rotavirus Vaccines. Viruses-Basel. 2022; 14.
.The Association between Symptomatic Rotavirus Infection and Histo-Blood Group Antigens in Young Children with Diarrhea in Pretoria, South Africa. Viruses-Basel. 2022; 14.
.A Pseudovirus Nanoparticle-Based Trivalent Rotavirus Vaccine Candidate Elicits High and Cross P Type Immune Response. Pharmaceutics. 2022; 14.
.Bovine natural antibody IgM inhibits the binding of human norovirus protruding domain to its HBGA receptors. FEBS Open Bio. 2022; 12:1489-1497.
.Structural Insight into Terminal Galactose Recognition by Two Non-HBGA Binding GI.3 Noroviruses. Journal of Virology. 2022; 96:e0042022.
.Quantitative norovirus viral load is not affected by home storage of stool. Transplant Infectious Disease. 2022; 24:e13826.
.Bioengineered pseudovirus nanoparticles displaying the HA1 antigens of influenza viruses for enhanced immunogenicity. Nano Research. 2022; 15:4181-4190.
.Norovirus Vaccines: Current Clinical Development and Challenges. Pathogens. 2021; 10.
.Intra-species sialic acid polymorphism in humans: a common niche for influenza and coronavirus pandemics?. Emerging Microbes and Infections. 2021; 10:1191-1199.
.Structural basis of P[II] rotavirus evolution and host ranges under selection of histo-blood group antigens. Proceedings of the National Academy of Sciences of USA. 2021; 118.
.Prevalence and Evolution of Noroviruses between 1966 and 2019, Implications for Vaccine Design. Pathogens. 2021; 10.
.Characterization of Functional Components in Bovine Colostrum That Inhibit Norovirus Capsid Protruding Domains Interacting with HBGA Ligands. Pathogens. 2021; 10.
.Genetic susceptibility to rotavirus infection in Chinese children: a population-based case-control study. Human Vaccines and Immunotherapeutics. 2021; 17:1803-1810.
.Effects of rotavirus NSP4 protein on the immune response and protection of the SR69A-VP8* nanoparticle rotavirus vaccine. Vaccine. 2021; 39:263-271.
.A Nanoparticle-Based Trivalent Vaccine Targeting the Glycan Binding VP8* Domains of Rotaviruses. Viruses-Basel. 2021; 13.
.Characterization of a hospital-based gastroenteritis outbreak caused by GII.6 norovirus in Jinshan, China. Epidemiology and Infection. 2020; 148:e289.
.Histo-blood group antigens as divergent factors of groups A and C rotaviruses circulating in humans and different animal species. Emerging Microbes and Infections. 2020; 9:1609-1617.
.Epidemiology and HBGA-susceptibility investigation of a G9P[8] rotavirus outbreak in a school in Lechang, China. Archives of Virology. 2020; 165:1311-1320.
.Structural Basis of Glycan Recognition in Globally Predominant Human P[8] Rotavirus. Virologica Sinica. 2020; 35:156-170.
.Molecular basis of P[II] major human rotavirus VP8* domain recognition of histo-blood group antigens. PLoS Pathogens. 2020; 16:e1008386.
.